Fig. 2: Multiphase contrast imaging and corresponding explant histology. Patient 6.

a Pre-SABR CT showing arterially enhancing Segment 4 HCC; (b) 3 months post-SABR CT showing reduction in the lesion size with minimal residual enhancement; (C1) Low power haematoxylin and eosin staining of tumour showing fibrosis, embolization material (black arrows), viable tumour (white arrows), and a background of cirrhosis (left hand side of image). (C2) Higher power view showing viable tumour (embolization material present on right hand side of image).